SEPTInvestingStart Free

VRTX SCHEDULE 13G/A: SEC filing

Capital Research Global Investors

Filed with the SEC on · accession 0001422848-26-000142

VRTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. Capital Research Global Investors filed an amended Schedule 13G indicating it beneficially owns 17,821,661 shares, or 7.0%, of Vertex Pharmaceuticals common stock as of September 30, 2026. The stock moved -0.7% by the first close after the filing.

Summary of the filing

Capital Research Global Investors filed an amended Schedule 13G indicating it beneficially owns 17,821,661 shares, or 7.0%, of Vertex Pharmaceuticals common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure with no intent to influence control of the company.

For details, click here →

Key details

Shares beneficially owned by Capital Research Global Investors$17.8M
Percent of class beneficially ownedPCT 7
Shares believed to be outstanding$253.5M
Reporting beneficial owner / institutional investorCapital Research Global Investors
Issuer of the securitiesVertex Pharmaceuticals Inc.
Senior vice president and associate general counsel, capital research and management companyJae Won Chung

How VRTX stock reacted

Close before

$542.62

Nov 12, 2026

First close after

-0.74%

$538.60

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for VRTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for VRTX?

Click here

Frequently asked questions

What did VRTX file with the SEC on Nov 13, 2026?

VRTX filed a SCHEDULE 13G/A (SEC filing). Capital Research Global Investors filed an amended Schedule 13G indicating it beneficially owns 17,821,661 shares, or 7.0%, of Vertex Pharmaceuticals common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure with no intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did VRTX stock react to this filing?

VRTX closed at $542.62 before the filing and $538.60 on Nov 13, 2026 (-0.74%).

Other VRTX SEC filings

Get alerts when VRTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
VRTX overviewVRTX analysisVRTX newsLatest SEC filings